Literature DB >> 24032681

Increased oxidative stress and decreased membrane fluidity in erythrocytes of CAD patients.

Edyta Pytel1, Małgorzata Olszewska-Banaszczyk, Maria Koter-Michalak, Marlena Broncel.   

Abstract

One of many risk factors for cardiovascular disease appears to be oxidative stress. To estimate possible changes in redox balance, membrane fluidity, and cholesterol level in erythrocytes was collected erythrocytes from patients diagnosed with coronary artery disease (CAD). The study included 20 patients with previous myocardial infarction occurring more than 6 months prior to the time of screening with low-density lipoprotein cholesterol (LDL-C) > 70 mg/dL and 21 healthy controls. The following parameters were studied: catalase, glutathione peroxidase (GPx), superoxide dismutase (SOD), thiobarbituric acid reactive substrates (TBARS), sulfhydryl (SH) groups in membrane protein, total cholesterol level, and erythrocyte membrane fluidity. Our study showed an increase in the level of lipid peroxidation (13%) and total cholesterol (19%), and a decrease in membrane fluidity (14%) in the subsurface layers and in the deeper layers of erythrocyte membrane (7%) isolated from patients with CAD in comparison to healthy controls. A significant decrease in catalase (10%) and SOD (17%) activities were also observed. No changes in GPx activity or the level of SH groups were observed. Our study indicates that there are disorders in the antioxidant system as well as changes in the membrane structure of erythrocytes obtained from CAD patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24032681     DOI: 10.1139/bcb-2013-0027

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  8 in total

1.  Impaired Erythrocyte Deformability in Patients with Coronary Risk Factors: Significance of Nonvalvular Atrial Fibrillation.

Authors:  Keita Odashiro; Toru Maruyama; Taku Yokoyama; Hisataka Nakamura; Mitsuhiro Fukata; Shioto Yasuda; Kazuyuki Saito; Takehiko Fujino; Koichi Akashi
Journal:  J Atr Fibrillation       Date:  2013-10-31

Review 2.  Melatonin: Regulation of Viral Phase Separation and Epitranscriptomics in Post-Acute Sequelae of COVID-19.

Authors:  Doris Loh; Russel J Reiter
Journal:  Int J Mol Sci       Date:  2022-07-23       Impact factor: 6.208

3.  A Dietary Pattern Derived from Reduced Rank Regression and Fatty Acid Biomarkers Is Associated with Lower Risk of Type 2 Diabetes and Coronary Artery Disease in Chinese Adults.

Authors:  Jowy Y H Seah; Choon Nam Ong; Woon-Puay Koh; Jian-Min Yuan; Rob M van Dam
Journal:  J Nutr       Date:  2019-11-01       Impact factor: 4.798

Review 4.  Crosstalk between red blood cells and the immune system and its impact on atherosclerosis.

Authors:  Brigitta Buttari; Elisabetta Profumo; Rachele Riganò
Journal:  Biomed Res Int       Date:  2015-02-04       Impact factor: 3.411

5.  Elevated Levels of Plasma Superoxide Dismutases 1 and 2 in Patients with Coronary Artery Disease.

Authors:  Ji-Ren Peng; Ting-Ting Lu; Hao-Teng Chang; Xuan Ge; Bian Huang; Wei-Min Li
Journal:  Biomed Res Int       Date:  2016-10-17       Impact factor: 3.411

6.  In Vitro Protective Effect of Phikud Navakot Extraction on Erythrocyte.

Authors:  Kanchana Kengkoom; Sumate Ampawong
Journal:  Evid Based Complement Alternat Med       Date:  2016-11-28       Impact factor: 2.629

7.  Correlated flickering of erythrocytes membrane observed with dual time resolved membrane fluctuation spectroscopy under different D-glucose concentrations.

Authors:  J Tapia; N Vera; Joao Aguilar; M González; S A Sánchez; P Coelho; C Saavedra; J Staforelli
Journal:  Sci Rep       Date:  2021-01-28       Impact factor: 4.379

8.  Erythrocyte membrane affinity chromatography, solid-phase extraction and UPLC-QTOF-MS/MS to screen active ingredients of Buyang Huanwu decoction.

Authors:  Aiming Yu; Huazhu Zheng; Xiangli Yan; Shengxin Wang; Xiao Shen; Haozhen Zheng; Yingjiao Meng; Lisheng Wang
Journal:  RSC Adv       Date:  2019-09-17       Impact factor: 4.036

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.